The control of gene expression in melanocytes and melanomas

Melanoma Research

Volumn 6, Issue 4, 1996, Pages 277-284

  Eisen, T G ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Melanoma; Transcription; Tyrosinase

Indexed keywords

HLA DR ANTIGEN; MONOPHENOL MONOOXYGENASE;

CARCINOGENESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; REVIEW;

EID: 0029834690     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199608000-00001     Document Type: Review

References (36)

1. Tjian R, Maniatis T. Transcriptional activation: a complex puzzle with few easy pieces. Cell 1994; 77: 5-8.
2. Jones N. Transcriptional activation by dimerisation: two sides of an incestuous relationship. Cell 1990; 61: 9-11.
3. Wegner D, Drolet D, Rosenfeld M. POU domain proteins: structure and function of developmental regulators. Curr Opin Cell Biol. 1993; 5: 488-498.
4. Li S, Crenshaw E, Rawson E, et al. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 1990; 347: 528-533.
5. Jackson I. Mouse coat colour mutations: a molecular resource which spans the centuries. Bioessays 1991; 13: 439-446.
6. Jinene-Cervantes C, Solano F, Kobayashi T, et al. A new enzymatic function in the melanogenic pathway. J Biol Chem 1994; 269: 17993-18001.
7. Yokoyama K, Suzuki H, Yasumoto K, et al. Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta 1994; 1217: 317-321.
8. Jackson IJ. A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. Proc Natl Acad Sci USA 1988; 85: 4392-4396.
9. Jackson I. Molecular and developmental genetics of mouse coat colour. Annu Rev Genet 1994; 28: 189-217.
10. Johnson R, Jackson I. Light is a dominant mouse mutation resulting in premature cell death. Nature Genet 1992; 1: 226-229.
11. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992; 71: 1195-1204.
12. Lu D, Willard D, Patel I, et al. Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 1994; 371: 799-802.
13. Chalepakis G, Goulding M, Read A, et al. Molecular basis of Splotch and Waardenbury Pax 3 mutations. Proc Natl Acad Sci USA 1994; 91: 3685-3689.
14. Hughes A. Newton V, Liu X, et al. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the mircophthalmia gene at chromosome 3 p12-p14. 1. Nature Genet 1994; 7: 509-512.
15. Hodgekinson CA, Moore KJ, Nakayama A, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic helix-loop-helix zipper protein. Cell 1993; 74: 395-405.
16. Russell D. Hereditary anaemias of the mouse: a review for geneticists. Adv Genet 1979; 20: 357-459.
17. Bentley NJ, Eisen T, Goding CR. Melanocyte specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and the role of the initiator. Mol Cell Biol; 1994; 14: 7996-8006.
18. Ganss R, Montoliu L, Monaghan AP, et al. A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J 1994; 13: 3083-3093.
19. Yavuzer U, Goding CR. Melanocyte-specific gene expression: role of repression and identification of a melanocyte-specific factor, MSF. Mol Cell Biol 1994; 14: 3494-3503.
20. Lowings P, Yavuzer U, Goding CR. Positive and negative elements regulate a melanocyte-specific promoter. Mol Cell Biol 1992; 12: 3653-3662.
21. Yavuzer U, Keenan E, Lowings P, et al. The microphthalmia gene product interacts with the retionoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 1995; 10: 123-134.
22. Braun T, Bober E, Arnold HH. Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5. Genes Dev 1992; 6: 888-902.
23. Cox PM, Temperley SM, Kumar H, et al. A distinct octamer-binding protein present in malignant melanoma cells. Nucleic Acids Res 1988; 16: 11047-11056.
24. Sturm RA, Bisshop F, Takahashi H, et al. A melanoma octamer binding protein is responsive to differentiating agents. Cell Growth Diff 1991; 2: 519-523.
25. Eisen T, Easty D, Bennett DC, et al. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Oncogene 1995; 11: 2157-2164.
26. Angus J, Thomson F, Murphy K, et al. The Brn-2 gene regulates the melanocyte phenotype and tumorigenic potential of human melanoma cells. Oncogene 1995; 11: 691-701.
27. He X, Treacy MN, Simmons DM, et al. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 1989; 340: 35-42.
28. Hara Y, Rovescalli AC, Kim Y, et al. Structure and evolution of four POU domain genes expressed in mouse brain. Proc Natl Acad Sci USA 1992; 89: 3280-3284.
29. Schreiber E, Tobler A, Malpiero U, et al. cDNA cloning of humn N-Oct 3, a nervous system specific POU domain transcription factor binding to the octamer DNA motif. Nucleic Acids Res 1993; 21: 253-258.
30. Fuji H, Hamada H. A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages. Neuron 1993; 11: 1197-1206.
31. Rawles P. Origin of pigment cells from the neural crest in the mouse embryo. Physiol Rev 1947; 20: 248-266.
32. Kapiloff M, Farkash Y, Wedner M, et al. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 1991; 25: 786-789.
33. Hunt G, Donatien P, Todd C, et al. Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res 1994; 7: 217-221.
34. Jans D, Jans P. Negative charge at the casein kinase II site flanking the nuclear localisation signal of the SV40 large T antigen is mechanistically important for enhanced nuclear import. Oncogene 1994; 9: 2961-2968.
35. Brooks G, Goss M, East J, et al. Growth of melanocytic cells is associated with down-regulation of PKC α, δ and ε isoforms. J Biol Chem 1993; 268: 23868-23875.
36. Leger H, Sock E, Renner K, et al. Functional interaction between the POU domain protein TST-1/Oct-6 and the high-mobility-group protein HMG-1/Y. Mol Cell Biol 1995; 15: 3738-3747.